Near complete deletion of KMT2D in a college student

被引:2
作者
Gooch, Catherine [1 ]
Souder, Jaclyn Paige [2 ]
Tedder, Matthew L. [3 ]
Kerkhof, Jennifer [4 ]
Lee, Jennifer A. [3 ]
Louie, Raymond J. [3 ]
Sadikovic, Bekim [4 ,5 ]
Fletcher, Robin S. [3 ]
Robin, Nathaniel H. [1 ]
机构
[1] Univ Alabama Birmingham, Dept Genet & Pediat, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Med Scientist Training Program, Birmingham, AL 35294 USA
[3] Greenwood Genet Ctr, Greenwood, SC 29646 USA
[4] London Hlth Sci Ctr, Mol Diagnost Div, Mol Genet Lab, London, ON, Canada
[5] Western Univ, Dept Pathol & Lab Med, London, ON, Canada
关键词
deletion; Kabuki syndrome; KMT2D; molecular testing; KABUKI SYNDROME; MLL2; EXPRESSION; DENDRIN; MUTATIONS; DIAGNOSIS; COHORT; GENES; KDM6A;
D O I
10.1002/ajmg.a.62652
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Pathogenic variants in KMT2D are typically associated with Kabuki syndrome (KS), a rare multisystem disorder. KS is characterized by facial dysmorphisms, intellectual disability, skeletal and dermatoglyphic differences, and poor growth. Seventy percent of individuals with clinically diagnosed KS have a confirmed pathogenic variant in KMT2D or less commonly KDM6A. The majority of mutations found in KMT2D are de novo nonsense or frameshift, with deletions and duplications rarely reported in the literature. Here, we present the case of near complete deletion of KMT2D in a college student with normal intelligence discovered via exome sequencing and EpiSign methylation testing. This case provides evidence that large deletions in KMT2D are compatible with normal intelligence and presents EpiSign as a method for discovering molecular causes of KS not identified by traditional molecular testing.
引用
收藏
页码:1550 / 1555
页数:6
相关论文
共 35 条
  • [1] Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders
    Aref-Eshghi, Erfan
    Kerkhof, Jennifer
    Pedro, Victor P.
    DI France, Groupe
    Barat-Houari, Mouna
    Ruiz-Pallares, Nathalie
    Andrau, Jean-Christophe
    Lacombe, Didier
    Van-Gils, Julien
    Fergelot, Patricia
    Dubourg, Christele
    Cormier-Daire, Valerie
    Rondeau, Sophie
    Lecoquierre, Francois
    Saugier-Veber, Pascale
    Nicolas, Gael
    Lesca, Gaetan
    Chatron, Nicolas
    Sanlaville, Damien
    Vitobello, Antonio
    Faivre, Laurence
    Thauvin-Robinet, Christel
    Laumonnier, Frederic
    Raynaud, Martine
    Alders, Marielle
    Mannens, Marcel
    Henneman, Peter
    Hennekam, Raoul C.
    Velasco, Guillaume
    Francastel, Claire
    Ulveling, Damien
    Ciolfi, Andrea
    Pizzi, Simone
    Tartaglia, Marco
    Heide, Solveig
    Heron, Delphine
    Mignot, Cyril
    Keren, Boris
    Whalen, Sandra
    Afenjar, Alexandra
    Bienvenu, Thierry
    Campeau, Philippe M.
    Rousseau, Justine
    Levy, Michael A.
    Brick, Lauren
    Kozenko, Mariya
    Balci, Tugce B.
    Siu, Victoria Mok
    Stuart, Alan
    Kadour, Mike
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2020, 106 (03) : 356 - 370
  • [2] Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes
    Aref-Eshghi, Erfan
    Rodenhiser, David I.
    Schenkel, Laila C.
    Lin, Hanxin
    Skinner, Cindy
    Ainsworth, Peter
    Pare, Guillaume
    Hood, Rebecca L.
    Bulman, Dennis E.
    Kernohan, Kristin D.
    Boycott, Kym M.
    Campeau, Philippe M.
    Schwartz, Charles
    Sadikovic, Bekim
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2018, 102 (01) : 156 - 174
  • [3] MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome
    Banka, S.
    Howard, E.
    Bunstone, S.
    Chandler, K. E.
    Kerr, B.
    Lachlan, K.
    McKee, S.
    Mehta, S. G.
    Tavares, A. L. T.
    Tolmie, J.
    Donnai, D.
    [J]. CLINICAL GENETICS, 2013, 83 (05) : 467 - 471
  • [4] How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum
    Banka, Siddharth
    Veeramachaneni, Ratna
    Reardon, William
    Howard, Emma
    Bunstone, Sancha
    Ragge, Nicola
    Parker, Michael J.
    Crow, Yanick J.
    Kerr, Bronwyn
    Kingston, Helen
    Metcalfe, Kay
    Chandler, Kate
    Magee, Alex
    Stewart, Fiona
    McConnell, Vivienne P. M.
    Donnelly, Deirdre E.
    Berland, Siren
    Houge, Gunnar
    Morton, Jenny E.
    Oley, Christine
    Revencu, Nicole
    Park, Soo-Mi
    Davies, Sally J.
    Fry, Andrew E.
    Lynch, Sally Ann
    Gill, Harinder
    Schweiger, Susann
    Lam, Wayne W. K.
    Tolmie, John
    Mohammed, Shehla N.
    Hobson, Emma
    Smith, Audrey
    Blyth, Moira
    Bennett, Christopher
    Vasudevan, Pradeep C.
    Garcia-Minaur, Sixto
    Henderson, Alex
    Goodship, Judith
    Wright, Michael J.
    Fisher, Richard
    Gibbons, Richard
    Price, Susan M.
    de Silva, Deepthi C.
    Temple, I. Karen
    Collins, Amanda L.
    Lachlan, Katherine
    Elmslie, Frances
    McEntagart, Meriel
    Castle, Bruce
    Clayton-Smith, Jill
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2012, 20 (04) : 381 - 388
  • [5] Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2
    Boegershausen, Nina
    Gatinois, Vincent
    Riehmer, Vera
    Kayserili, Huelya
    Becker, Jutta
    Thoenes, Michaela
    Simsek-Kiper, Pelin OEzlem
    Barat-Houari, Mouna
    Elcioglu, Nursel H.
    Wieczorek, Dagmar
    Tinschert, Sigrid
    Sarrabay, Guillaume
    Strom, Tim M.
    Fabre, Aurelie
    Baynam, Gareth
    Sanchez, Elodie
    Nuernberg, Gudrun
    Altunoglu, Umut
    Capri, Yline
    Isidor, Bertrand
    Lacombe, Didier
    Corsini, Carole
    Cormier-Daire, Valerie
    Sanlaville, Damien
    Giuliano, Fabienne
    Le Quan Sang, Kim-Hanh
    Kayirangwa, Honorine
    Nuernberg, Peter
    Meitinger, Thomas
    Boduroglu, Koray
    Zoll, Barbara
    Lyonnet, Stanislas
    Tzschach, Andreas
    Verloes, Alain
    Di Donato, Nataliya
    Touitou, Isabelle
    Netzer, Christian
    Li, Yun
    Genevieve, David
    Yigit, Goekhan
    Wollnik, Bernd
    [J]. HUMAN MUTATION, 2016, 37 (09) : 847 - 864
  • [6] Neurobehavioral features in individuals with Kabuki syndrome
    Caciolo, Cristina
    Alfieri, Paolo
    Piccini, Giorgia
    Digilio, Maria Cristina
    Lepri, Francesca Romana
    Tartaglia, Marco
    Menghini, Deny
    Vicari, Stefano
    [J]. MOLECULAR GENETICS & GENOMIC MEDICINE, 2018, 6 (03): : 322 - 331
  • [7] Yes-associated Protein (YAP) Promotes Cell Survival by Inhibiting Proapoptotic Dendrin Signaling
    Campbell, Kirk N.
    Wong, Jenny S.
    Gupta, Ritu
    Asanuma, Katsuhiko
    Sudol, Marius
    He, John Cijiang
    Mundel, Peter
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (24) : 17057 - 17062
  • [8] Cheon Chong-Kun, 2015, Korean J Pediatr, V58, P317, DOI 10.3345/kjp.2015.58.9.317
  • [9] Dissecting KMT2D missense mutations in Kabuki syndrome patients
    Cocciadiferro, Dario
    Augello, Bartolomeo
    De Nittis, Pasquelena
    Zhang, Jiyuan
    Mandriani, Barbara
    Malerba, Natascia
    Squeo, Gabriella M.
    Romano, Alessandro
    Piccinni, Barbara
    Verri, Tiziano
    Micale, Lucia
    Pasqualucci, Laura
    Merla, Giuseppe
    [J]. HUMAN MOLECULAR GENETICS, 2018, 27 (21) : 3651 - 3668
  • [10] Dendrin expression in glomerulogenesis and in human minimal change nephrotic syndrome
    Duner, Fredrik
    Patrakka, Jaakko
    Xiao, Zhijie
    Larsson, Jenny
    Vlamis-Gardikas, Alexios
    Pettersson, Erna
    Tryggvason, Karl
    Hultenby, Kjell
    Wernerson, Annika
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (08) : 2504 - 2511